Cognitive changes in co‐pathological Alzheimer’s disease and Synuclein diseases: A study of amyloid, tau, and alpha‐Synuclein biomarkers in the ADNI dataset
Jian Wang, Ming Lu, Sergey Shcherbinin, Amanda Morris, Saima Rathore, Leonardo Iaccarino, Michael Pontecorvo, Emily C Collins, Mark Mintun · 2025
Read Cognitive changes in co‐pathological Alzheimer’s disease and Synuclein diseases: A study of amyloid, tau, and alpha‐Synuclein biomarkers in the ADNI dataset by Jian Wang, Ming Lu, Sergey Shcherbinin, Amanda Morris, Saima Rathore, Leonardo Iaccarino, Michael Pontecorvo, Emily C Collins, Mark Mintun (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11716814.txt.
Description
Jian Wang and eight co-authors published a study in 2025 on what happens when Alzheimer's disease and synuclein diseases occur in the same brain. The two illnesses have distinct protein markers, yet they often overlap in older patients. The team used a national data set to ask how the mix shapes thinking over time.
They combined amyloid and tau scans with spinal fluid tests for both tau and a synuclein marker. The fluid synuclein test matched autopsy findings well. Thinking scores were then tracked for up to three years against each marker alone and in combination. Mixed disease is common, and knowing which proteins are present may sharpen forecasts for each patient.
Catalog record
| CREATOR | Jian Wang, Ming Lu, Sergey Shcherbinin, Amanda Morris, Saima Rathore, Leonardo Iaccarino, Michael Pontecorvo, Emily C Collins, Mark Mintun |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |